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Socioeconomic inequalities in mortality and importance of
perceived control: cohort study
Hans Bosma, Carola Schrijvers, Johan P Mackenbach
Perceived control has convincingly been suggested to
be a key concept in explaining socioeconomic
differences in health.1 Some empirical evidence exists
of a higher prevalence of low control beliefs (such as
powerlessness or fatalism) in lower socioeconomic
groups and that this is relevant to socioeconomic
inequalities in general health.2 However, a systematic
examination of the extent to which perceived control
contributes to socioeconomic inequalities in mortality
is lacking. This is important, as attention has recently
shifted towards psychological and psychosocial expla›
nations of socioeconomic inequalities in health.
Participants, methods, and results
Data were collected in 1991 within the framework of a
general population study of the health and living
conditions of the population of Eindhoven and its
surroundings (the GLOBE study).3 We invited a
random subsample for interview. The response
rate was 80% and not related to demographic
characteristics. Interview data were available for 1220
men and 1242 women aged 25›74 (51 on average).
Detailed information was obtained on socioeconomic
status (educational, occupational, and income level),
health status (self reports of at least one severe chronic
condition (339, 14%), at least one less severe chronic
condition (1062, 43%), and less than good general
health (737, 30%)), and perceived control. Perceived
control was measured with an 11 item Dutch version
of Rotter’s locus of control scale (Cronbach’s á = 0.84).
This asks respondents to indicate agreement with
statements using a five point scale—for example,
“I often feel a victim of circumstances” (1 = strongly
disagree, 5 = strongly agree).4 The scores were
summed (mean (SD) = 31 (7.1)). Municipal population
registers provided information on all cause mortality
during a six year follow up. There were 122 deaths,
and only 30 people were lost to follow up. The
analyses were done with Cox proportional hazards
model.
The table shows that the socioeconomic indicators
were related to mortality in the expected direction. For
example, the risk of dying for people with only
primary schooling was 2.64 times higher than the risk
for the highest educated group. The association was
not significant for income level. Perceived low control
was more common among low socioeconomic groups
and it was also related to mortality. People scoring 1
SD higher on the perceived control scale (indicating
decreased control) had a 1.45 times higher mortality
risk (95% confidence interval 1.19 to 1.75). Adjust›
ment for perceived control substantially decreased the
mortality ratios for the lower socioeconomic groups.
The mortality ratio for people with only primary
schooling decreased to 1.76. This implies that more
than half ((2.64 − 1.76)/(2.64 − 1) = 0.54) of the raised
risk in this group is accounted for by perceived low
control. The average percentage of raised mortality
risk in the lowest socioeconomic groups that was
accounted for by perceived low control was 51%
(range: 37›65%).
Comment
Our findings indicate that low socioeconomic status is
related to mortality partly because people with a low
socioeconomic status more often perceive low control.
This supports hypotheses on the importance of
perceived control for socioeconomic inequalities in
health.1 Perceptions of low control partly originate in
adverse socioeconomic conditions during childhood.2
Effect of perceived control on mortality ratios (95% confidence intervals) for three indicators of socioeconomic status
No of
people*
No (%) who
died during
follow up
Adjusted
mortality ratio†
Mortality ratio
additionally adjusted for
perceived control
% reduction in
mortality ratio
between 2 models
Educational level:
University/higher vocational 469 9 (2) 1.00 1.00
Intermediately high 489 19 (4) 1.48 (0.65 to 3.39) 1.22 (0.53 to 2.82) 54
Intermediately low 909 36 (4) 1.67 (0.80 to 3.52) 1.29 (0.60 to 2.78) 57
Primary school only 541 58 (11) 2.64 (1.26 to 5.51) 1.76 (0.80 to 3.85) 54
Occupational level:
Higher grade professionals 259 7 (3) 1.00 1.00
Lower grade professionals 724 31 (4) 1.86 (0.81 to 4.27) 1.51 (0.64 to 3.53) 41
Self employed 86 5 (6) 1.56 (0.49 to 4.99) 1.31 (0.41 to 4.21) 45
Manual workers 606 49 (8) 2.43 (1.08 to 5.44) 1.72 (0.74 to 3.99) 50
Income level:
Highest quarter 552 15 (3) 1.00 1.00
Second highest quarter 522 19 (4) 1.46 (0.73 to 2.93) 1.29 (0.64 to 2.59) 37
Second lowest quarter 542 41 (8) 1.76 (0.94 to 3.28) 1.33 (0.70 to 2.56) 57
Lowest quarter 547 35 (6) 1.62 (0.85 to 3.11) 1.22 (0.62 to 2.40) 65
*Numbers differed between the socioeconomic indicators because the indicators had differing numbers of people with missing data. Housewives were excluded from
the analyses for occupational level. Excluded people did not differ in their risk of mortality from those included.
†Adjusted for age, sex, severe chronic conditions, less severe chronic conditions, and general health in 1991.
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We found that low socioeconomic status in adulthood
was related to adverse changes in control beliefs during
the six year follow up (results not shown), suggesting
that adult socioeconomic conditions further contribute
to beliefs of low control. More information is needed
on the specific socioeconomic correlates that induce
beliefs of low control as these may be easier to modify
than the beliefs themselves. Low job control may be
one of these conditions.5 Other studies with larger
numbers are needed to examine the behavioural or
psychophysiological pathways through which per›
ceived control affects mortality. Our findings empha›
sise that only by examining psychological mechanisms
more thoroughly can we determine the complex path›
ways through which social structure affects individual
disease and mortality.
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Cost effectiveness analysis of inhaled anticholinergics for
acute childhood and adolescent asthma
Joanne Lord, Francine M Ducharme, Ronald J Stamp, Peter Littlejohns, Rachel Churchill
A recent systematic review by the Cochrane Airways
Group showed that adding multiple doses of
anticholinergics to â2 agonists is safe and effective in
improving lung function and avoiding hospital
admission for school aged children and adolescents
attending casualty departments with severe acute
asthma.1 The estimated reduction in the risk of
admission was 9.4% (0.4% to 18.4%). This intervention
presumably improves bronchodilatation until systemic
corticosteroids take effect. Evidence of cost effective›
ness, however, is lacking. To clarify whether scarce
health resources should be spent on this intervention
we conducted an economic evaluation.
Methods and results
We used various assumptions to estimate the financial
implications of treatment (see table on the BMJ ’s
website). The costs of drug administration were not
included, as anticholinergics are always given with â2
agonists and involve little additional manipulation.
The cost of nebulisers, other drugs, and the casualty
attendance were also excluded. No consideration was
given to possible changes in length of stay in casualty.
The effect of changing the various assumptions was
tested by simple, one way, sensitivity analysis, and by
multivariate probabilistic sensitivity analysis.2 The
latter is a simulation approach that enables estimation
of uncertainty ranges containing 95% of replicated
results.3
We estimated that treatment would cost about £8
(uncertainty range £1 to £47) per admission avoided
(table). This implies a net saving of £80 (£0 to £157)
per severe case treated. Varying the risk reduction
within 95% confidence limits varied the mean net
saving from £3 to £157 per severe case treated. More
precision is expected when the Cochrane review is
updated. Varying the cost of hospital admissions
within the interquartile range for English providers
(£620 to £907) varied the mean savings from £58
to £85 per severe case treated. Changes to the dose
and unit cost of ipratropium had very little effect on
the results.
Further assumptions were used to extrapolate the
findings to a national level. About 7200 children aged
5›15 years are admitted from casualty with a diagnosis
of asthma each year (hospital episode statistics 1988 to
1996). About 40% of children in this age group
attending casualty with asthma are admitted.4 We
assumed that 50% of people with asthma attending
casualty have severe asthma.5 The rate of uptake of the
review recommendations was assumed to be 5% a
website
extra
A table with
baseline data is on
the BMJ’s website
www.bmj.com
Results of baseline analysis, with uncertainty ranges estimated by probabilistic
sensitivity analysis
Per severe case treated
Best estimate Uncertainty range*
Admissions avoided† 0.09 0›0.18
Cost of treatment‡ £0.75 £0.28›£1.40
Savings due to avoided admissions§ £81 £0›£158
Cost of treatment per admission avoided¶ £8 £1›£47
Net monetary saving to the health service** £80 £0›£157
*Interval containing 95% of 5000 simulation replications. †Risk difference estimated by meta›analysis.1
‡Cost of ipratropium bromide 25p per 0.25 mg (from British National Formulary March 1999), and total
dose per patient 0.625 mg (median for multiple dose protocols included in the meta›analysis1). Authors
assumed that one mild to moderate case is treated for every five severe cases treated.
§Mean cost of non›elective inpatient admissions £860 (NHS Executive’s reference costs 1998 (HRG D21 and
D22)). ¶Cost of treatment divided by the number of admissions avoided.
**Savings due to avoided admissions minus the cost of treatment.
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